Immune Microenvironment and Molecular Mechanism of Glioma
A special issue of Biology (ISSN 2079-7737). This special issue belongs to the section "Cancer Biology".
Deadline for manuscript submissions: 24 August 2024 | Viewed by 133
Special Issue Editor
Special Issue Information
Dear Colleagues,
Gliomas are the most common malignant primary brain tumors in adults. Conventionally, gliomas have been classified based on their histology by immunohistochemistry methods. However, in 2016, the World Health Organization (WHO) introduced molecular markers in its classification, enabling a more accurate description and prognosis for these tumors according to their molecular characteristics. Of note, the latest treatment for gliomas is surgical resection, combined with radiotherapy and chemotherapy. However, relapse is common, especially for glioblastomas (GBM; WHO grade IV), which are refractory to standard treatments because of their infiltration nature. Therefore, current therapies are only a temporary and limited solution. More recently, cancer immunotherapy, which has shown impressive results in the treatment of extracranial tumor types, is now being used for GBM treatment. However, disappointing outcomes of clinical studies involving immunotherapy treatment exposed the need for new approaches against GBM. Furthermore, GBM’s microenvironment is rich in immunosuppressive factors, such as cytokines like transforming growth factor-β and IL-10, which can polarize immune cells into a regulatory profile, thus contributing to tumor growth. This Special Issue will focus on original papers covering topics related to “Immune Microenvironment and Molecular Mechanism of Glioma” that present advances in those fields.
Dr. Carolina Cristina Jancic
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gliomas
- tumor microenvironment
- immune response
- tumor evasion
- tumor resistance
- immunotherapy
